APC c.70_72delinsTGT ;(p.R24C)

Variant ID: 5-112090657-CGA-TGT

NM_000038.5(APC):c.70_72delinsTGT;(p.R24C)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Acetylation-dependent regulation of BRAF oncogenic function.

Cell Reports
Dai, Xiangpeng X; Zhang, Xiaoling X; Yin, Qing Q; Hu, Jia J; Guo, Jianping J; Gao, Yang Y; Snell, Aidan H AH; Inuzuka, Hiroyuki H; Wan, Lixin L; Wei, Wenyi W
Publication Date: 2022-01-18

Variant appearance in text: APC: R24C
PubMed Link: 35045286
Variant Present in the following documents:
  • Main text
View BVdb publication page



Acetylation-dependent regulation of BRAF oncogenic function.

Cell Reports
Dai, Xiangpeng X; Zhang, Xiaoling X; Yin, Qing Q; Hu, Jia J; Guo, Jianping J; Gao, Yang Y; Snell, Aidan H AH; Inuzuka, Hiroyuki H; Wan, Lixin L; Wei, Wenyi W
Publication Date: 2022-01-18

Variant appearance in text: APC: R24C
PubMed Link: 35045286
Variant Present in the following documents:
  • Main text
View BVdb publication page



CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin.

Oncotarget
Kendall, Jed J JJ; Chaney, Katherine E KE; Patel, Ami V AV; Rizvi, Tilat A TA; Largaespada, David A DA; Ratner, Nancy N
Publication Date: 2016-08-16

Variant appearance in text: APC: R24C
PubMed Link: 27448963
Variant Present in the following documents:
  • Main text
View BVdb publication page



The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.

Advances In Immunology
Ward, Jeffrey P JP; Gubin, Matthew M MM; Schreiber, Robert D RD
Publication Date: 2016

Variant appearance in text: APC: R24C
PubMed Link: 26922999
Variant Present in the following documents:
  • Main text
View BVdb publication page



Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells.

Oncotarget
Liu, Yugang Y; Qiang, Wenan W; Xu, Xiaofei X; Dong, Ruifen R; Karst, Alison M AM; Liu, Zhaojian Z; Kong, Beihua B; Drapkin, Ronny I RI; Wei, Jian-Jun JJ
Publication Date: 2015-11-17

Variant appearance in text: APC: R24C
PubMed Link: 26472020
Variant Present in the following documents:
  • Main text
View BVdb publication page



Current status and evolution of preclinical drug development models of epithelial ovarian cancer.

Frontiers In Oncology
Konstantinopoulos, Panagiotis A PA; Matulonis, Ursula A UA
Publication Date: 2013-12-11

Variant appearance in text: APC: R24C
PubMed Link: 24377084
Variant Present in the following documents:
  • Main text
View BVdb publication page



CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.

Human Vaccines & Immunotherapeutics
Diken, Mustafa M; Attig, Sebastian S; Grunwitz, Christian C; Kranz, Lena L; Simon, Petra P; van de Roemer, Niels N; Vascotto, Fulvia F; Kreiter, Sebastian S
Publication Date: 2013-09

Variant appearance in text: APC: R24C
PubMed Link: 23877042
Variant Present in the following documents:
  • Main text
View BVdb publication page



Melanoma-infiltrating dendritic cells: Limitations and opportunities of mouse models.

Oncoimmunology
Klarquist, Jared S JS; Janssen, Edith M EM
Publication Date: 2012-12-01

Variant appearance in text: APC: R24C
PubMed Link: 23264904
Variant Present in the following documents:
  • Main text
  • onci-1-1584.pdf
View BVdb publication page